Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-05-21 @ 9:12 PM
Study NCT ID:
NCT00771667
Status:
COMPLETED
Last Update Posted:
2013-04-01
First Post:
2008-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
Sponsor:
Centocor, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Crohn's Disease | View |